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NEURAL REGENERATION RESEARCH 
PERSPECTIVE
Harnessing the stem cell properties of 
pericytes to repair the brain 
Over the last ten years or so, it has become apparent that pericytes 
have the potential to differentiate into other cell types which may help 
in the repair and regeneration of tissue after injury. In fact, pericytes 
have been described as a precursor to mesenchymal stem cells. Their 
location at the interface between the microvasculature and the brain 
parenchyma means they are ideally positioned to initiate repair and 
regeneration in response to various factors. In this perspective, we will 
highlight how pericytes have stem cell potential alongside their role in 
regulating processes, such as angiogenesis and inflammation, and dis-
cuss how pericytes could be harnessed to promote tissue repair in the 
brain (Figure 1).
Pericytes and their stem cell potential in the brain: Pericytes are 
multi-functional cells located within the basement membrane that sur-
rounds capillaries throughout the body. They can regulate blood flow, 
are involved in angiogenesis and inflammation, and display stem cell-
like properties. Within the brain, pericytes form part of the neurovas-
cular unit and help maintain the blood-brain barrier (BBB).
A recurring feature in the pericyte literature is the ability of peri-
cytes to act as stem cells and differentiate into multiple cell types. Some 
authors use the terms “pericyte” and “mesenchymal stem cell” inter-
changeably, while others argue that pericytes give rise to mesenchymal 
stem cells and are in fact the only true pluripotent stem cells in adult 
vertebrates (Davidoff, 2019). 
The question of whether pericytes are indeed stem cells has been hot-
ly debated in recent years with no consensus yet reached. It is generally 
accepted that pericytes share many features and markers of mesenchy-
mal stem cells, but as both populations lack definitive markers and are 
heterogeneous, it is very difficult to demonstrate whether they are truly 
one and the same. Both in vivo and in vitro, pericytes appear to express 
markers typical of mesenchymal stem cells, such as CD44, CD73, CD90 
and CD105. In addition, pericytes have been shown to have the poten-
tial to differentiate into a wide variety of cell types including chron-
drocytes, osteoblasts, fibroblasts and smooth muscle cells. In the brain, 
pericytes have been shown to differentiate into neural and vascular cells 
(Nakagomi et al., 2015). 
Within the periphery at least, the prevailing view is that pericytes 
are likely the in vivo precursors of mesenchymal stem cells and as such 
constitute an organ- and tissue-independent pool of pluripotent cells 
that reside in the microvasculature, and can respond to insult or injury 
in tissue-appropriate ways depending on cues from their surroundings 
(Yianni and Sharpe, 2018). However, one study suggested that while 
pericytes (defined as Tbx18-expressing cells) differentiate into multiple 
cell types in vitro, they do not contribute to other cell lineages in vivo 
either in physiological or pathological conditions (Guimaraes-Camboa 
et al., 2017).
Role of pericytes in repair: The location of pericytes at the interface 
between tissue cells and the vasculature places them in an ideal position 
to respond to injury. Their central location allows them to act as a para-
crine signalling hub in which they receive signals from within the tissue 
itself or from the circulation. Pericytes have many important roles in 
the repair process including driving angiogenesis and vascular repair, 
mediating the influx of leukocytes and the inflammatory response, and 
guiding the removal of toxic species from the tissue. In addition to their 
potential stem cell activity outlined above, pericytes appear to play a 
critical role in the repair process of the brain and in the periphery.
Angiogenesis, the formation of new blood vessels, is a critical part of 
the tissue repair process. When injury occurs, which can damage both 
the tissue cells and the vasculature, new blood vessels can help supply 
the recovering area with critical nutrients to enable the reestablish-
ment of that tissue. Pericytes can migrate to newly formed endothelial 
sprouts to help stabilise the vessel and make them functional but it is 
also possible that vessel formation can be driven by pericytes prior to 
endothelial cell involvement (Ribatti et al., 2011). Multiple signalling 
factors are involved in pericyte-driven angiogenesis including plate-
let-derived growth factor B, Angiopoietin, vascular endothelial growth 
factor and Notch (Ribatti et al., 2011), with loss of endothelial plate-
let-derived growth factor B leading to pericyte loss and microvascular 
abnormalities (Bjarnegard et al., 2004). In the brain, the knockdown of 
platelet-derived growth factor receptor β signaling can lead to pericyte 
loss, microhaemorrhages and a disrupted BBB (Bjarnegard et al., 2004), 
demonstrating the importance of pericytes to maintaining vascular sta-
bility and function.
A critical component of the tissue repair process is inflammation. 
The brain has specialised resident immune cells called microglia, but 
also relies on the influx of circulating leukocytes to aid in clean-up and 
repair after injury. Experiments in human cultures have shown that 
pericytes have substantial immunological complexity which contributes 
to propagation and resolution of inflammation (Rustenhoven et al., 
2017). Pericytes express and release cytokines and chemokines such as 
CCL2, CXCL8 and interleukin-1β as well as adhesion molecules to at-
tract and direct leukocytes and activate glial cells in the brain (Rusten-
hoven et al., 2017). In vivo, pericytes are the first-responders to systemic 
inflammation in the brain, releasing chemokines to coordinate changes 
in brain function and directing the passage of extravasated leukocytes 
Figure 1 Pericytes have multiple properties that can 
lead to repair of tissue. 
Pericytes residing on blood vessels can drive angio-
genesis, mediate the inflammatory response, have 
stem cell properties by differentiating into other cell 
types, and can phagocytose material to clean up de-
bris. The coordination of these responses can aid in 
the repair and regeneration of injured or diseased tis-
sue, with evidence showing that this can occur in the 
brain.
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(Duan et al., 2018). In addition, pericytes can alter BBB properties in 
response to inflammatory stimuli to enable the passage of leukocytes 
into the brain (Rustenhoven et al., 2017). Pericytes also appear to have 
MHCII complexes that could facilitate antigen uptake and presentation, 
but lack the co-stimulatory molecules to activate naïve T cells, and so 
pericytes likely influence adaptive immunity through the reactivation 
of T cells that have already been primed by other antigen presenting 
cells (Rustenhoven et al., 2017).
Another aspect of pericyte function is the protection of the brain 
through clearance of toxic species. Following ischemia, pericytes can 
differentiate into multiple cell types including glial cells (Nakagomi 
et al., 2015) enabling phagocytosis of cellular debris to clean up the 
damaged region. However, even resident pericytes on blood vessels can 
exhibit phagocytosis, as they are able to clear aggregated amyloid beta 
through an low-density lipoprotein receptor-related protein-1-mediat-
ed mechanism (Ma et al., 2018). Therefore, pericytes can help prevent 
the build-up of waste and debris in the brain.
Could pericytes be used as a type of stem cell treatment? The ver-
satile and multipotent nature of pericytes makes them attractive as a 
therapeutic option to facilitate repair, particularly through their roles 
in angiogenesis, phagocytosis and inflammation. A number of re-
search groups have explored this idea in the brain using experimental 
models. Fibroblast-derived pericytes were implanted into the brains of 
an aged Alzheimer’s disease mouse model (APP/PS1) where they led 
to increased cerebral blood flow and clearance of toxic amyloid beta 
thereby reducing plaque burden (Tachibana et al., 2018). In addition, 
an abstract published in 2017 reported that administration of adi-
pose-derived perivascular stem cells (CD146+, neural glial antigen 2+, 
platelet-derived growth factor receptor beta+) to rats undergoing mid-
dle cerebral artery occlusion showed improved somatosensory recovery 
and increased capillary density in the ischemic border zone 28 days lat-
er (Ogay et al., 2017). The administration of pericytes for a regenerative 
approach has also been utilized in peripheral tissues such as the heart 
and bone.
One of the issues for pericyte delivery to the brain, and one which 
has limited the use of stem cell therapy in the past, is the difficulty in 
crossing the BBB. Therefore, strategies must be developed to enable 
exogenously administered pericytes to readily enter the brain and exert 
any reparative effects if they are going to be a viable therapeutic option. 
A recent study attempted to achieve this by using mannitol in canines 
to transiently open the BBB and allow autologous pericytes derived 
from adipose tissue to enter the brain following intra-arterial injection 
(Youn et al., 2015). They showed that transient opening of the BBB with 
mannitol resulted in a significantly greater number of pericytes enter-
ing the brain from the circulation, indicating that there is potential with 
this technique. 
The process of isolating, culturing and testing functionality of peri-
cytes is critical for their success as a cellular therapy. Many methods 
have been developed to obtain functional pericytes from a range of 
tissues including skeletal muscle, adipose tissue and the placenta. Func-
tional in vitro assays such as the stabilisation of endothelial networks 
will need to be used to confirm the functionality of isolated pericytes. 
Autologous pericyte cellular therapies present an attractive proposition 
given that they could be administered back to the same patient, thereby 
avoiding the problems of immune rejection that plague non-autologous 
cellular therapy.
Nomenclature: Unfortunately, the pericyte field has been complicated 
by confusing nomenclature, with multiple names for pericytes being 
used interchangeably. For example, pericytes have been called peri-
vascular cells, perivascular stem cells and mesenchymal vascular stem 
cells. So, is everyone talking about the same cell type? The heteroge-
neity of pericytes and inconsistent results with cellular markers has 
meant that researchers could be labeling these as different cell types 
when they may in fact be the same. Therefore, to move forward as a 
field, we must determine what is specifically meant by a pericyte and 
remain consistent in our definition while being aware that there likely 
exist many sub-types of pericytes which may explain the differential 
findings reported in the literature.
Conclusion: While the jury is still out on whether pericytes function 
as stem cells in vivo or whether their ability to form other cell types 
is merely a function of culture conditions and/or artificial manipula-
tion, this may actually be irrelevant to their potential for therapeutics. 
There is little doubt that pericytes exist within the microvasculature of 
all tissues, so there is potential to harness their stem cell properties to 
promote regeneration and repair even it requires some manipulation 
either in vitro or in vivo. The potential of pericyte therapy for many 
brain diseases is promising, and future research will determine whether 
differentiation of endogenous pericytes or exogenous administration of 
pericytes is the optimal strategy.
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